Viewing Study NCT04240704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:12 PM
Ignite Modification Date: 2026-03-30 @ 5:37 PM
Study NCT ID: NCT04240704
Status: TERMINATED
Last Update Posted: 2025-10-10
First Post: 2020-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkins Lymphoma View
None Chronic Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CLL View
None NHL View
None CCR7 View
None JBH492 View
None ADC View
None Chronic Lymphocytic Leukemia View
None Non-Hodgkins Lymphoma View